COMMUNIQUÉS West-GlobeNewswire

Unum Therapeutics to Host Second Quarter 2018 Financial Results Conference Call and Webcast on August 13, 2018 at 5:00 P.M. ET
06/08/2018
CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (Nasdaq:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]
Bellicum Pharmaceuticals Appoints Dr. Thierry Darcis as General Manager of Europe to Lead the Anticipated Launch of BPX-501
06/08/2018
HOUSTON, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Summit Therapeutics to Present at the Canaccord Genuity Growth Conference
06/08/2018
OXFORD, United Kingdom and CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT) (AIM: SUMM) announces that Glyn Edwards, Chief Executive Officer, will present at the Canaccord [...]
T2 Biosystems Reports Granting of Inducement Awards
06/08/2018
LEXINGTON, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
International Stem Cell Corporation Developed 3D Liver Structures
06/08/2018
CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
AnaptysBio to Present at the 2018 Wedbush PacGrow Healthcare Conference
06/08/2018
SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, [...]
U.S. FDA Grants Fast Track Designation for BioCryst’s BCX7353
06/08/2018
RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, [...]
C-RAD Web Presentation Half-Year Report 2018
06/08/2018
Presentation of the report for the first half of the fiscal year 2018: Date: Friday August 17, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-Year Report 2018 Procedure: Please register online through the [...]
ASLAN Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
06/08/2018
SINGAPORE, Aug. 06, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]
Bio-on chooses Siemens control and supervisory systems to develop Industry 4.0 in the bioplastic sector
06/08/2018
Press Joint press release Siemens and Bio-On Milan, 06 August 2018 Bio-on's new production hub has begun producing bioplastic with a Siemens control and supervisory system The new Bio-on plant was created innovatively, [...]
Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2018
06/08/2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France ERN France, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Monthly information related to total number of voting rights and shares [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 juillet 2018
06/08/2018
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France ERN France, 06 août 2018 (GLOBE NEWSWIRE) -- Information mensuelle relative au nombre total de droits de vote et d’actions composant [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2018
BURLINGTON, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to six new employees for an aggregate of 14,800 shares of common stock. [...]
SeaSpine Reports Granting of Inducement Awards
03/08/2018
CARLSBAD, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
GBT Announces New Employment Inducement Grants
03/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that, on August 1, 2018, the compensation committee of the Company’s board of directors [...]
EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2018
WATERTOWN, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Acer Therapeutics Announces Closing of Underwritten Public Offering
03/08/2018
NEWTON, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
Advanced Proteome Therapeutics Announces Non-Brokered Private Placement
03/08/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ [...]
California, Some Cities, Want to Ban Affordable Health Insurance, States the Association of American Physicians and Surgeons (AAPS)
03/08/2018
TUCSON, Ariz., Aug. 03, 2018 (GLOBE NEWSWIRE) -- The Trump Administration is liberalizing the rules to allow more people to have short-term, limited duration health insurance, but the rule is on a “crash course with a [...]

Pages